Patient-oriented research

We aim at improving quality of life of millions of patients.

500 million people worldwide suffer from symptomatic osteoarthritis. Tendinopathies and ostearthritis (OA) are extremely common and have a direct impact in millions of people’s quality of life. Athletes, elderly and women are amongst the most affected.


In patients' lifes

Sport woman suffering from pain in knee. Tendon problems and Joint inflammation on dark background. Healthcare and medical.

Frequent joint pain often associated to deformation of the bones and muscle contractures.

Loss of mobility and autonomy which leads to great psycological wear.
Long-term postoperative rehabilitation.

A common and eroding health problem


exposed to progressive joint degeneration

0 %

world population
over 60 affected by ostearthritis

0 M

procedures annually worldwide

Filling a critical gap
in treatment

To date, non of existing surgical and non-surgical treatments provide with a full recovery of strength and functionality of the damaged tissue.

Seeking better and faster healing

We work for providing all patients with a new regenerative therapy for articular, tendinous or ligament diseases of weight-bearing joints.

↑ 10- %

Ankle joints
functionality recovery ratios


Reduction of recovery time


Patients' recovery


Decrease postoperative inflammatory response and risk of implant rejection


Mimic joint tissues properties and resist high forces quickly after implantation


 Consolidate the integration of the graft to the native tissue


This project has received funding from the European Union’s Horizon 2020
research and innovation framework programme under the Grant Agreement #952981